GlaxoSmithKline Pharmaceuticals Limited — Important, 29-04-2025: General Updates

GlaxoSmithKline Pharmaceuticals has announced a board meeting. Shareholders approved the appointment of Mr. Somasundaram Palamadairamaswamy and Mr. Anup Wadhawan as Independent Directors for five years. Mr. Juby Chandy was re-appointed as whole-time Director & CFO, with approved remuneration for two years. These leadership changes strengthen the company’s governance and strategic direction.